JNJ241213C130000
- 25.70
- 0.000.00%
Johnson & Johnson Newsroom
Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Today's Analyst Rating | Citi Cuts Its Price Target Cut on Johnson & Johnson to $175, Deutsche Bank Upgrades Coca-Cola to Buy
Jim Cramer Bullish On Netflix Nearing $1,000 And AMD's 'Cheap' Valuation Despite Nvidia Dominance
The latest research results of Johnson & Johnson (JNJ.US) CAR-T Therapy have been announced.
Johnson & Johnson (JNJ.US) recently announced the latest research results of the phase 3 clinical trial CARTITUDE-4.
SpaceX share buyback valuation soars to $350 billion
Musk's SpaceX company reached a valuation of 350 billion dollars by issuing additional shares. A copy of the takeover offer shows that SpaceX and investors agreed to buy $1.25 billion of shares from insiders at a price of $185 per share. This round of financing did not include raising new capital, as the takeover offer was a second sale of existing shares. Notably, as part of the offer, SpaceX will buy up to $0.5 billion in common stock, a rare share buyback showing the private company's financial position. The company usually provides a second round of financing twice a year to allow employees and their
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Cuts Target Price to $175
Express News | J&J : Citigroup Cuts Target Price to $175 From $185
Investors in Johnson & Johnson (NYSE:JNJ) Have Unfortunately Lost 4.4% Over the Last Three Years
Why Is Johnson & Johnson (JNJ) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
BofA Restarts Coverage of 11 Large-cap Biopharmas
Market Falls Wednesday, but Googles Chip Impresses | WST
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
10 Health Care Stocks With Whale Alerts In Today's Session
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
The Analyst Landscape: 15 Takes On Johnson & Johnson
Press Release: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Express News | B of A Securities Reinstates Neutral on Johnson & Johnson, Announces $166 Price Target
Johnson & Johnson Analyst Ratings